Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)

Name: Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)
Published: 2021
License: Public Domain

R-Pharm · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

coronavirus covid-19-pandemic sars-cov-2

covid-19, sars-cov-2, severe acute respiratory syndrome coronavirus 2, 2019-ncov, 2019 novel coronavirus, respiratory disease, lung disease, covid-19 pandemic, coronavirus, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)

Related documents